Fei Jiang

Chief Investment Officer bei CHINA MEDICAL SYSTEM HOLDINGS LIMITED

50 Jahre

Consumer Services

Health Technology

Profil

Fei Jiang currently holds the position of Non-Executive Director at Tyligand Bioscience Ltd. starting in 2026.
Dr. Jiang is also a Non-Executive Director at Eastenova (Chengdu) Biotechnology Co., Ltd. since 2025.
Additionally, Dr. Jiang has been the Chief Investment Officer-Greater China at China Medical System Holdings Ltd. since 2022.
Dr. Jiang earned a doctorate from Syracuse University in 2006 and an undergraduate degree from East China University of Science & Technology in 1998.

Aktive Positionen von Fei Jiang

Unternehmen	Position	Beginn
CHINA MEDICAL SYSTEM HOLDINGS LIMITED	Chief Investment Officer	01.01.2022
Tyligand Bioscience Ltd Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics	Direktor/Vorstandsmitglied	01.04.2024

Alle aktiven Positionen von Fei Jiang

Ausbildung von Fei Jiang

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Fei Jiang im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Syracuse University Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
China Medical System Holdings Ltd. China Medical System Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes prescription drugs and pharmaceutical products	Health Technology
East China University of Science & Technology East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tyligand Bioscience Ltd Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics	Health Technology